Impacts of hippocampal blood flow on changes in left ventricular wall thickness in patients with chronic heart

Hideaki Suzuki1, Yasuharu Matsumoto1, Koichiro Sugimura1

  • 1Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Insights

Altered hippocampal perfusion in chronic heart failure (CHF) patients may worsen cardiac structure through increased depressive symptoms. This study reveals a link between brain blood flow, mood, and heart changes in CHF.

Area of Science:

  • Neurocardiology
  • Psychocardiology
  • Medical imaging

Background:

  • Depressive symptoms are linked to increased mortality and hospitalization in chronic heart failure (CHF) patients.
  • The underlying mechanisms connecting depression and cardiac issues in CHF remain unclear.
  • Hippocampal perfusion alterations are implicated in depressive symptoms.

Purpose of the Study:

  • To investigate the association between hippocampal perfusion and cardiac structure/function changes in CHF patients.
  • To explore if altered hippocampal blood flow relates to depressive symptoms and cardiac alterations.
  • To examine the neural substrate of depressive symptoms in relation to cardiac remodeling in CHF.

Main Methods:

  • Utilized baseline data from 70 CHF patients in the Brain Assessment and Investigation in Heart Failure Trial (B-HeFT).
  • Assessed hippocampal cerebral blood flow (CBF), Geriatric Depression Scale (GDS) scores, and echocardiographic parameters.
  • Employed voxel-wise regression and structural equation modeling to analyze relationships over a 3.1-year follow-up.

Main Results:

  • Baseline anterior hippocampal CBF negatively correlated with changes in left ventricular posterior wall thickness (PWT).
  • Depressive symptoms positively correlated with baseline anterior CBF and negatively with PWT changes.
  • Found direct effects of hippocampal CBF on PWT thinning and indirect effects mediated by depressive symptoms.

Conclusions:

  • Provides the first evidence linking altered hippocampal perfusion to cardiac structural changes in CHF patients.
  • Suggests that changes in hippocampal blood flow may drive cardiac alterations via increased depressive symptoms.
  • Highlights a potential neurobiological pathway connecting brain function, mood, and cardiac health in chronic heart failure.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
607
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
315
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
310
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
333